(4R)-4-[3-(cyclopentyloxy)-4-methoxyphenyl]pyrrolidin-2-one
| Title | Journal |
|---|---|
| Dual β2-adrenoceptor agonists-PDE4 inhibitors for the treatment of asthma and COPD. | Bioorganic & medicinal chemistry letters 20120215 |
| SAR of a series of 5,6-dihydro-(9H)-pyrazolo[3,4-c]-1,2,4-triazolo[4,3-alpha]pyridines as potent inhibitors of human eosinophil phosphodiesterase. | Journal of medicinal chemistry 20070125 |
| Synthesis and evaluation of N-aryl pyrrolidinones as novel anti-HIV-1 agents. Part 1. | Bioorganic & medicinal chemistry letters 20060701 |
| Three-dimensional structures of PDE4D in complex with roliprams and implication on inhibitor selectivity. | Structure (London, England : 1993) 20030701 |
| Crystal structure of 5-t-butoxycarbonyl-1-benzoyl-2-pyrrolidinone, an intermediate in the synthesis of (-)-rolipram. | Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20020701 |
| Novel selective PDE4 inhibitors. 3. In vivo antiinflammatory activity of a new series of N-substituted cis-tetra- and cis-hexahydrophthalazinones. | Journal of medicinal chemistry 20020606 |
| Novel selective PDE4 inhibitors. 2. Synthesis and structure-activity relationships of 4-aryl-substituted cis-tetra- and cis-hexahydrophthalazinones. | Journal of medicinal chemistry 20010802 |